US › Healthcare

Vivani Medical Inc. (VANI)

US · Healthcare · Biotechnology

$1.40+5.26%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

Net profit

$-6.8M

Profit YoY

-7.6%

EPS

$-0.08

EPS estimate

$-0.08

EPS came in at -0.08 against a street estimate of -0.08 — a beat of 0.0%.

Key statistics

Market cap

$110.4M

Forward P/E

0.0

P/B

5.78

Book value

$0.23

EPS (TTM)

$-0.40

52-week high

$1.92

52-week low

$0.92

50-day MA

$1.27

200-day MA

$1.30

Beta

3.29

Analyst view

Analysts rate Vivani Medical Inc. a buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $3.83.

Shareholding

Insiders

57.94%

Institutions

6.44%

Largest institutional holders

Fund	Stake
Vanguard Capital Management, LLC	1.78%
Tanager Wealth Management LLP	0.70%
Geode Capital Management, LLC	0.70%
Tudor Investment Corp Et AL	0.49%
UBS Group AG	0.39%
Commonwealth Equity Services, LLC	0.38%
BlackRock Inc	0.34%
Vanguard Fiduciary Trust Co	0.31%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Vivani Medical Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.